An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.
This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.
In this Product Explainer, Sexual Health Physician Dr Terri Foran explains estradiol and progesterone combined hormone therapy, the first and only body-identical combined treatment for post-menopausal women (6 mins).
No longer is it okay to just monitor a patient with mild hyperparathyroidism as research shows the untreated condition is associated with a significantly increased risk of cardiovascular death
Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture
Tuesday 9th June, 7pm - 9pm AEST
Speaker
Dr Philip Tong
Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney
What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.